identi CRP is an immunoturbidimetry monospecific antisera reagent for CRP analysis in serum. Lower detection limit is 0.1 mg/dL. Linearity of the reagent is 22 mg/dL. Reagent is liquid stable and ready to use

The ADVIA® 1800 Clinical Chemistry System pushes the limit of productivity. Its extensive menu allows integration of testing for clinical chemistry, drugs-of-abuse, therapeutic drug monitoring (TDM) and specific proteins such as cystatin C and CardioPhase® hsCRP. The ADVIA 1800 Clinical Chemistry System offers: Throughput of up to 1,800 tests per hour to keep pace with workload peaks 200 basic metabolic panels per hour to meet turnaround-time demands Large onboard reagent capacity and optional concentrated reagents to reduce interruptions Optimal standardization of reagents and systems for efficient consumable usage Refrigerated onboard storage of controls and reagents for extended stability and increased productivity Automation-ready design: no additional hardware required Features & Benefits The ADVIA 1800® Clinical Chemistry System pushes the limit of productivity in the core lab and meets the turnaround-time (TAT) goals of today’s laboratories. Its extensive menu allows integration of general clinical chemistry testing with testing for drugs-of-abuse, TDM, special chemistry, and specific proteins such as cystatin C and CardioPhase® hsCRP. Automation-ready design Point-in-space aspiration enables connectivity to a track, VersaCell® System. Redundant sample loading provides built-in backup and easy handling of non-routine samples. Direct sampling from track prevents tubes being detained at an analyzer and reduces aliquoting. Peak productivity Throughput of up to 1,800 tests per hour provides the speed to keep pace with workload peaks. Throughput of 200 basic metabolic panels per hour helps to meet turnaround-time demands. Automatic Sample Retain technology lets you perform reruns and dilutions without the need to retrieve primary tubes. Consolidate chemistry testing on one system with a comprehensive menu, consistent cycle times, speed, and open application capability. Total system reliability Minimal-maintenance ISEs Robust hardware and simplified software design, with automatic calibration validation and tracking Advances in reagent onboard stability, calibration frequency, interference reduction and assay linearity expansion Direct water connection Remote diagnostics and Inter-Laboratory Quality Control (ILQC) options Easy efficiency Large onboard reagent capacity and optional concentrated reagents reduce interruptions. High-resolution touchscreen delivers push-button operation. Reagent pause capability and onboard Sample Pause button make loading easy. Minimal maintenance requirements, including no-maintenance oil bath, reduce hands-on time. Sample integrity checking, include serum indices reporting, short-sample flagging, and clot detection, reducing the need for manual intervention.

Based on Mindray’s continuous innovation in hematology field, BC-5130 is especially tailored to assist diagnostic labs who need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5130 is a highly user-friendly and innovative analyzer that offers cost efficient CBC and 5-part white cell differential results. It is targeted to fulfill and exceed the demands of our global customers by providing more accurate, more efficient and more innovative solutions for labs. Improved DC impedance technology is used to count and size the RBC and PLT. The smaller counting aperture (50 μm in diameter) provides better performance on samples with low PLT. Efficient Only three routine reagents are required. These have 2 years shelf life and also less consumed by BC-5130. Original QC and calibrator are also provided to ensure the hematology analyzer’s traceability and testing quality. WBC 5-Part differentiation,25 reportable parameters & 23 research parameters,3 histograms Whole blood Mode, Capillary whole blood mode & Prediluted Mode Tri-angle Laser Scatter + Chemical dye + Flow cytometry technology Dedicated optical counting channel for Basophil measurement 10.4 inch large TFT touch screen with user-friendly software Large storage capacity: Up to 1,50,000 samples Throughput:60 samples/Hour Compact Two kinds of lyse reagents are located inside of BC-5130, which helps the small labs to save space. BC-5130, the 5-part hematology analyzer offers a great solution for clinical labs, especially for those who have limited space. Its compact foot-print is a result of innovative technology improvements, including miniaturized semi-conductor laser source, highly integrated electronic boards and optimized liquid handling system. BC-5130 inherits it’s convenient and proven powerful software design from BC-6800 and BC-3600 platforms, the friendly interface is ideal for small sized labs. Running capillary blood through the sample probe directly is more convenient for the users in children’s hospitals, etc. For Prediluted mode, BC-5130 has higher dilution ratio than other 5-part hematology There’s NLR parameter in each CBC+DIFF result. Neutrophil-to-lymphocyte ratio (NLR) is calculated by dividing neutrophil count by lymphocyte count, usually from peripheral blood sample. In laboratory medicine, NLR is used as a marker of subclinical inflammation. According to clinical studies, NLR can be used as a prognostic factor of severe illness in COVID-19 patients. BC-5130 supports bi-directional LIS with test results and patient information. HL7 protocol is supported as well. Technology Compared with traditional helium neon laser or argon laser, semi -conductor laser has smaller size, lower cost and longer life cycle.

Since the company was founded, Mindray has been continuously exploring new ways to improve diagnostic confidence. Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings ultrasound image quality to a higher level by zone acquisition and channel data processing. As well as the premium level image quality, Resona 7 also enhances clinical research capabilities with the revolutionary V Flow for vascular hemodynamic evaluation, and the most intelligent plane acquisition from 3D datasets for fetal CNS diagnosis. Combining the most intuitive gesture-based multi-touch operation and all the essential clinical features, Resona 7 is truly leading new waves in ultrasound innovation. With core platform advantages of ZST+ The channel data based ZST+ is an extraordinary innovation, representing an ultrasound evolution. Transforming ultrasound metrics from conventional beamforming to channel data based processing, ZST+ is able to deliver multiple imaging advances: Advanced Acoustic Acquisition, Dynamic Pixel Focusing, Sound Speed Compensation, Enhanced Channel Data Processing and Total Recall Imaging. Advanced features V Flow V Flow (Vector Flow) is a novel approach for vascular hemodynamic analysis. V Flow uses color coded vector arrows to indicate the velocity’s magnitude and direction of blood cells. With ultra-high frame rates, it provides extremely accurate and angle-independent visualization of complex vascular hemodynamic profiles. With comprehensive data information, V Flow is the most valuable tool for vascular clinical research. resona-7-fig3-1-pc UWN+ Contrast Imaging UWN+ (Ultra-Wideband Non-linear Plus) CEUS enables the Resona 7 to detect and utilize both the 2nd harmonic and non-linear fundamental signals, generating significantly enhanced images, resulting in greater sensitivity of minor signals and longer agent duration with lower MI. Forwarding smart to clinical intelligence The Resona 7 elevates clinical intelligence with a complete solution that enables clinicians to manage both routine and advanced studies more efficiently,consistently, and accurately, from acquisition to calculation. As an example, Smart Planes CNS shows exceptional intelligence in accurate diagnosis and analysis of the fetal central nervous system (CNS) Smart Planes CNS Mindray’s exclusive pioneering technology positions the Resona 7 as the industry’s first ultrasound system to allow fully automatic and accurate detection of the most significant planes and frequently used measurements of fetal CNS, leading to intelligent diagnosis, improved throughput, and reduced user dependence. Smart Planes CNS provides a user-friendly tool that greatly improves scanning efficiency through increased accuracy coupled with automated operation. With a simple button click on a 3D fetal brain volume image, the standard CNS scanning planes (MSP, TCP, TTP and TVP) and a range of related anatomical measurements (BPD, HC, OFD, TCD, CM and LVW) are obtained immediately. Smart Face Acquiring an optimal view of the fetal face in 3D ultrasound is cumbersome and time-consuming. In some cases, it is impossible to get rid of the occlusions such as cord, placenta, uterus and extremities. The new Resona 7 with Zone Intelligence provides a fast and intelligent optimization for fetal face with simply one-touch. It can immediately remove occlusions in the volume data, eliminate unwanted noise information, and generate an optimal view of the fetal face with minimal effort. Ergonomics The Resona 7 is designed around you. Gesture-based operation opens up a new trend in cart-based ultrasound with an agile, smart, and intuitive user experience beyond your expectations. Gel warmer’s three level temperature and swiveling angle adjustment of the control panel delivers great patient comfort and user convenience.

The OnSite Troponin I Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of cardiac Troponin I (cTnI) in human serum, plasma or whole blood at a level equal to or higher than 1 ng/mL. It can be performed within 15 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite Troponin I Combo Rapid Test is intended to be used by healthcare professionals as an aid in the diagnosis of acute myocardial infarction (AMI). Any use or interpretation of this preliminary test result must also rely on patient’s symptoms and the professional judgment of a physician. A more precise test method such as an instrument method must be used to confirm the test result obtained by this device. Normally the level of cTnI in the blood is very low. cTnI is released into the blood stream in forms of free cTnI and cTnI-C-T complex at 4-6 hours after myocardial cell damage. The elevated level of cTnI could be as high as 50 ng/mL during 60-80 hours after AMI and remains detectable for up to 10-14 days post AMI. Therefore, circulating cTnI is a specific and sensitive marker for AMI. Clinical performance: Relative Sensitivity: 95.8% (95% CI: 91.5-97.9%) compared to a reference CLIA Relative Specificity: 99.7% (95% CI: 98.8-99.9%) Analytical sensitivity: The detection limit of cTnI is 1.0 ng/mL or greater in serum, plasma or whole blood specimen Cross-reactivity: No cross reactivity with 10 µg/mL skeletal muscle TnI, 2,000 ng/mL cardiac muscle TnT, 20 µg/mL cardiac muscle Myosin Dose hook effect: No hook effect was observed for cTnI at concentrations up to 3,521 µg/mL Interference: No interference was seen with 20 mg/dl Acetaminophen, 20 mg/dl Acetylsalicylic acid, 10.5 g/dl Albumin, 20 mg/dl Ascorbic acid, 1,000 mg/dl Bilirubin, 20 mg/dl Caffeine, 800 mg/dl Cholesterol, 200 mg/dl Creatinine, 20 mg/dl Gentistic acid, 1,000 mg/dl Hemoglobin, 600 mg/dl Oxilic acid, 1,600 mg/dl Triglycerides Shelf life: 24 months Individually sealed foil pouches containing: One cassette device One desiccant Plastic droppers Sample diluent (REF SB-R3002, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Insert MedlinePlus: Troponin Test Poster

The OnSite hCG Combo Rapid Test is a lateral flow chromatographic immunoassay for the early detection of pregnancy, by providing a quick direct visual test for the placental hormone, hCG in human serum, plasma and urine. It can be performed within 5-10 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite hCG Combo Rapid Test is not intended for quantitative results, nor for over the counter (OTC) sales. It is intended to meet all requirements for yielding rapid, easily read, qualitative results for the purpose of early pregnancy detection via assay of hCG, a placental hormone that may be present in human serum, plasma or urine. The hCG detection limit the OnSite hCG Combo Rapid Test is 12.5 mIU/mL in serum or plasma specimen, and 25 mIU/mL in urine specimen. It is designed for professional use only, and provides only preliminary analytical data. For a final diagnosis of pregnancy, a more specific alternative clinical method must be used to obtain a confirmed analytical result. Clinical accuracy: In comparison with a reference chemiluminecsence or ELISA, hCG detection is 100% sensitivity and 100% specificity in urine specimens 100% sensitivity and 99.5% specificity in serum specimens Analytical sensitivity: 100% positive detection rate at 12.5 mIU/mL in serum/plasma specimens and 100% positive detection rate at 25 mIU/mL in urine specimens Analytical specificity: no cross reactivity with 1,000 mIU/mL human luteinizing hormone (hLH), 1,000 mIU/mL human follicle stimulating hormone (hFSH), and 1,000 mIU/mL human thyroid stimulating hormone (hTSH) Dose hook effect: no dose hook effect was observed for hCG at concentrations up to 500,000 mIU/mL in urine specimens Interference: No interference was seen with 35 biological and chemical analytes commonly found in OTC, prescriptions or abuse drugs in urine or serum/plasma specimens, as well as pH 4-9 (see detail in the package insert) Shelf life: 24 month Kit box package: 1. Individually sealed foil pouches containing; a. One dip strip device b. One desiccant 2. One package insert (instruction for use) Tube package: 1. Strip Package 2. One desiccant 3. One package insert (instruction for use) CTK Products at a Glance Drugs.com: Overview of Human Chorionic Gonadotropin Inserts

The OnSite hCG Combo Rapid Test is a lateral flow chromatographic immunoassay for the early detection of pregnancy, by providing a quick direct visual test for the placental hormone, hCG in human serum, plasma and urine. It can be performed within 5-10 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite hCG Combo Rapid Test is not intended for quantitative results, nor for over the counter (OTC) sales. It is intended to meet all requirements for yielding rapid, easily read, qualitative results for the purpose of early pregnancy detection via assay of hCG, a placental hormone that may be present in human serum, plasma or urine. The hCG detection limit of the OnSite hCG Combo Rapid Test is 12.5 mIU/mL in serum or plasma specimen, and 25 mIU/mL in urine specimen. It is designed for professional use only, and provides only preliminary analytical data. For a final diagnosis of pregnancy, a more specific alternative clinical method must be used to obtain a confirmed analytical result. Clinical accuracy: In comparison with a reference chemiluminecsence or ELISA, hCG detection is 100% sensitivity and 100% specificity in urine specimens 100% sensitivity and 99.1% specificity in serum specimens Analytical sensitivity: 100% positive detection rate at 12.5 mIU/mL in serum/plasma specimens and 100% positive detection rate at 25 mIU/mL in urine specimens Analytical specificity: no cross reactivity with 1,000 mIU/mL human luteinizing hormone (hLH), 1,000 mIU/mL human follicle stimulating hormone (hFSH), and 1,000 mIU/mL human thyroid stimulating hormone (hTSH) Dose hook effect: no dose hook effect was observed for hCG at concentrations up to 500,000 mIU/mL in urine specimens Interference: No interference was seen with 35 biological and chemical analytes commonly found in OTC, prescriptions or abuse drugs in urine or serum/plasma specimens, as well as pH 4-9 (see detail in the package insert) Shelf life: 24 month Individually sealed foil pouches containi a. One cassette device b. One plastic dropper c. One desiccant One package insert (instruction for use) CTK Products at a Glance Drugs.com: Overview of Human Chorionic Gonadotropin Inserts CATALOG # PRODUCT QUANTITY SPECIMEN R1001C hCG Combo Rapid Test CE 30/kit S/Urine OTHER PRODUCTS YOU MIGHT BE INTERESTED IN.. CATALOG # PRODUCT QUANTITY SPECIMEN R1001S hCG Combo Rapid Test (Strip) CE 50/kit, 100/kit S/Urine

Buy Accurex H12 Hemoglobin Test Strips Online – for better result & accuracy. These Hemoglobin strips are used with URIT Hemoglobin Meter, for the quantitative measurement of total hemoglobin in capillary and venous whole blood. These hb strips are to be used by health care professionals only, not to be used for patient self-testing. Accurex HB Test Strips come with a pack size of 50 strips. The Accrues test strip utilizes Dry Chemistry Colorimeter Method (Azido methemoglobin Method). Meter’s optical detectors automatically measure the change in the membrane Buy Accurex H12 Hemoglobin Test Strips Online – for better result & accuracy. These Hemoglobin strips are used with URIT Hemoglobin Meter, for the quantitative measurement of total hemoglobin in capillary and venous whole blood. These hb strips are to be used by health care professionals only, not to be used for patient self-testing. Accurex HB Test Strips come with a pack size of 50 strips. The Accrues test strip utilizes Dry Chemistry Colorimeter Method (Azido methemoglobin Method). Meter’s optical detectors automatically measure the change in the membrane Operation Principle: The test strip utilizes Dry Chemistry Colorimeter Method (Azido methaemoglobin Method). When a drop of whole blood is applied to the test spot on the strip, blood immediately disperses within the membrane, contacting the reagent. The meter’s optical detectors avtomatically measure the change in membrane reflectance. The intensity of reflectance is inversely proportional to the hemoglobin concentration. Blood Sample Collection: Fresh or EDTA-anticoagulated capillary or venous whole blood may be used. If an EDTA – treated sample is refrigeratted to come to the room temperature before testing. EDTA treated blood samples should be mixed using end to and inversions at least 8 times prior to use, and should be tested within 24nours Do not use the haemolytic sample anticogulants other than EDTA are not recommended for use. Caution: 1. Same as all diagnostic tests, hemoglobin test results should be evaluated with the specific patient’s condition. Any results demonstrating the inconsistency with the patient’s clinical status should be repeated or supplemented with additional test data. 2. Do not touch the test membrane by hand 3. H12 Hemoglobin Test Strips are one-off product, do not use again Storage & Preparation: 1.H12 Hemoglobin Test Strips should be stored at O C-30 C dry and dark places, 2 C – B C is the best storage environment emperatures recommended. Keep away from direct sunlight and heat, must not be frozen, If the container was stored in refrigerated before first use, please don’t take it back into the refrigerator again after first use. 2. H12 Hemoglobin Test Strips are ready to use. No additional preparation is required 3. Enclosed desiccants with lest strip. Remove only those strips needed for testing. The remaining lest strips should be resealed in their onginal container and used up in 3 months after first use. Do not use lest strips and throw away alter expiry date. 4. Use the strip immediately once taking it out af the container, otherwise the result will be incorrect 5. Do not fold or cut the test strip. 6. Used lest strips cannot be used again, dispose them as normal medical waste Direction for Use Operating Instructions: 1. URIT Hemoglobin Meter, H12 Hemoglobin Test Strip, Lancing Device, and disposable blood taking needle. 2. Test steps: 1) Turn the meter on and input the Code Card. Check the Code Card displaying on the meter to ensure it to match the Code Card printed on the lest strip container. Otherwise, the result is incorrect. 2) Massage the patient’s finger from the knuckle up to the tip to stimulate blood flow. Clean the sample area with alcohol and wipe it dry with a sterile gauze pad. 3) Insert the lest strip into the strip holder with the notched end in first and the hole facing up. 4) Puncture the skin on the lower side of fingertip with blood collection needle, and remove 13-15 TIL of whole biood with capillary or other micro blood collection apparatus. While waiting for the instrument to display the blood drop symbol, quickly add the drops to the test hole on the reagent sheet. Please make sure that the blood drop volume can completely cover the test hole but not overflow the test hole. 5) The meter starts the test automatically after the blood sample disperses Once the lest is in process do nol disturb or move the meter or test strip, or press any key. The test result will display within 12 seconds. Qualtiy Control Procedure: Use only H12 Hemoglobin Test Strip with QC substance to perform QC. The range of QC substance is the numerical range indicated on the label of the QCsubstance or test strips. When to do a QCtest: 1. Whenever you suspect that the meter or test strips are not working properly. 2. If your hemoglobin test results are not consistent with how you feel. Other Info Limitations of test Method: H12 Hemoglobin Test Strip is only suitable for testing fresh or whole capillary blood or whole venous blood containing EDTA anticoagulants. Do not use serum, plasma or arterial blood

Buy AccuTest Typhoid IgG/IgM Rapid Card Test (5 Tests) Online from Accurex. The Typhoid IgG/IgM Rapid Test is used for detection & differentiation of anti-Salmonella typhi (S. typhi) IgG and IgM in human whole blood / serum / plasma. This Typhoid test is used as a screening test and as an aid in the diagnosis of infection with S. typhi. Salmonella typhi bacteria causes typhoid Typhoid fever, typhoid symptoms symptoms are likely to develop gradually – appearing one to three weeks after exposure to the disease. There are various typhoid treatment & typhoid vaccine which can be opted after the detetction of Typhoid. Typhoid fever is caused by S. typhi, a Gram-negative bacterium. Worldwide an estimated 17 million cases and 600,000 associated deaths occur annually. Patients who are infected with HIV are at significantly increased risk of clinical infection with S. typhi. Evidence of H. pylori infection also presents an increased risk of acquiring typhoid fever. 1-5% of patients become chronic carrier harboring S. typhi in the gall bladder. The clinical diagnosis of typhoid fever depends on the isolation of S. typhi from blood, bone marrow or a specific anatomic lesion. In the facilities that can not afford to perform this complicated and time-consuming procedure, Filix-Widal test is used to facilitate the diagnosis. However, many limitations lead to difficulties in the interpretation of the Widal test. In contrast, the Typhoid IgG/IgM Rapid Test is a simple and rapid laboratory test. The test simultaneously detects and differentiates the IgG and the IgM antibodies to S. typhi specific antigen thus to aid in the determination of current or previous exposure to the S. typhi. PRINCIPLE The Typhoid IgG/IgM Rapid Test is a lateral flow immunochromatographic assay. The test cassette consists of: 1) a pink-purple colored conjugate pad containing recombinant S. typhi H antigen and O antigen conjugated with colloid gold (Typhoid conjugates) and rabbit IgG-gold conjugates, 2) a nitrocellulose membrane strip containing two test region (Test line M and G) and a control region (control line). The test line ‘M’ is pre-coated with monoclonal anti-human IgM for the detection of IgM anti-S. typhi, test line ‘G’ is pre-coated with monoclonal anti-human IgG for the detection of IgG anti-S. typhi , and the C band is pre-coated with goat anti rabbit IgG. When an adequate volume of test specimen is dispensed into the sample well of the cassette, the test specimen migrates by capillary action across the test cassette. Anti-S. typhi IgM if present in the patient specimen will bind to the Typhoid conjugates. The immunocomplex is then captured on the membrane by the pre-coated anti-human IgM antibody at test region ‘M’, forming a pink-purple line at ‘M’ region, indicating a S. typhi IgM positive test result. Anti-S. typhi IgG if present in the patient specimen will bind to the Typhoid conjugates. The immunocomplex is then captured by the pre-coated reagents on the membrane, forming a pink-purple line at test region ‘G’, indicating a S. typhi IgG positive test result. Absence of any pink-purple line at test region (M and G) suggests a negative result. The test contains an internal control (control line) which should exhibit a pink-purple line of the immunocomplex of goat anti rabbit IgG/rabbit IgG-gold conjugate regardless of the color development on any of the test region. Otherwise, the test result is invalid and the specimen must be retested with another device. PRECAUTION 1. This package insert must be read completely before performing the test. Failure to follow the insert gives inaccurate test results. 2. Do not open the sealed pouch, unless ready to conduct the assay. 3. Do not use expired devices. 4. Bring all reagents to room temperature (15°C-30°C) before use. 5. Do not use the components in any other type of test kit as a substitute for the components in this kit. 6. Do not use hemolized blood specimen for testing. Wear protective clothing and disposable gloves while handling the kit reagents and clinical specimens. Wash hands thoroughly after performing the test. 7. Users of this test should follow the US CDC Universal Precautions for prevention of transmission of HIV, HBV and other blood-borne pathogens. 8. Do not smoke, drink, or eat in areas where specimens or kit reagents are being handled. 9. Dispose of all specimens and materials used to perform the test as biohazardous waste. 10. Handle the Negative and Positive Control in the same manner as patient specimens. 11. The testing results should be read within 15 minutes after a specimen is applied to the sample well or sample pad of the device. Read result after 15 minutes may give erroneous results. 12. Do not perform the test in a room with strong air flow, ie. an electric fan or strong air-conditioning. Other Info STORAGE AND STABILITY Typhoid IgG/IgM test card should be stored at 4-40°C. The card may be stored at room temperature but not exceeding 40°C in the original sealed pouch. The shelf life or expiry of the card is printed on Pouch as well as carton label. The test kit should be kept away from direct sunlight, moisture and heat.